https://www.selleckchem.com/products/AZD7762.html
The patient has not received adjuvant therapy and has remained alive without any evidence of disease for 30 months, suggesting that the prognosis might be better than that of typical C11orf95-RELA fusion-positive ependymoma. The study aimed to investigate the efficacy of vonoprazan 10mg compared with 20mg in patients with erosive esophagitis. Seventy-three patients with erosive esophagitis were randomly divided into two groups either vonoprazan 20mg (n = 37) or 10mg (n = 36). They were administered each dose for 4weeks as the initial tr
Curtir
Comentario
Compartilhar
